Table 2 Inhibitory effects on fMLF/CB-activated neutrophils of isolates and synthetics.
Compounds | IC50 (μM) | Compounds | IC50 (μM) | ||
---|---|---|---|---|---|
O2.− generation | HNE | O2.− generation | HNE | ||
1 | 1.54 ± 0.29 | >10 | 9 | 0.99 ± 0.26 | 1.07 ± 0.33 |
2 | 2.81 ± 1.00 | >10 | 10 | >10 | >10 |
3 | 2.56 ± 1.06 | >10 | 11 | >10 | >10 |
4 | 1.70 ± 0.28 | >10 | 12 | >10 | >10 |
6 | 1.92 ± 0.54 | >10 | 13 | >10 | >10 |
7 | 1.49 ± 0.38 | >10 | 14 | >10 | >10 |
QA | >10 | >10 | 15 | >10 | 7.99 ± 1.18 |
CA | 1.42 ± 0.02 | >10 | 17 | >10 | >10 |
RA | 1.29 ± 0.09 | >10 | 18 | >10 | >10 |
THBA | 1.14 ± 0.08 | >10 | 19 | >10 | >10 |
p-CA | >10 | >10 | 11-1 | >10 | >10 |
3-HCA | >10 | >10 | 11-2 | >10 | >10 |
FA | >10 | >10 | 14-1 | 4.77 ± 0.40 | 2.84 ± 1.02 |
— | — | 15-1 | 0.14 ± 0.09 | 0.06 ± 0.01 | |
— | — | 15-2 | 0.26 ± 0.10 | 0.20 ± 0.02 |